| Les deux révisions précédentes
Révision précédente
Prochaine révision
|
Révision précédente
|
start [2022/02/21 16:15]
remyfroissart |
start [2024/02/07 12:36] (Version actuelle)
remyfroissart |
| **Research scientist, \\ | **Research scientist, \\ |
| permanent position in the "Centre National de Recherche Scientifique" (CNRS)** | permanent position in the "Centre National de Recherche Scientifique" (CNRS)** |
| | |
| | {{::logo_cnrs_2019_rvb.png?50|}} |
| |
| ---- | ---- |
| Département [[ https://www.mivegec.ird.fr/fr/equipes/see|"Perturbation, Évolution, Virulence"]] -- Équipe [[ https://virostyle.cnrs.fr/team/|"Virostyle"]]\\ | Département [[ https://www.mivegec.ird.fr/fr/equipes/see|"Perturbation, Évolution, Virulence"]] -- Équipe [[ https://virostyle.cnrs.fr/team/|"Virostyle"]]\\ |
| Membre du [[ https://crees-montpellier.com/members/14-member-page/crees-member-14.html|Centre de Recherche sur l'écologie & l'évolution de la Santé (CREES)]]\\ | Membre du [[ https://crees-montpellier.com/members/14-member-page/crees-member-14.html|Centre de Recherche sur l'écologie & l'évolution de la Santé (CREES)]]\\ |
| Membre du bureau d'administration du réseau [[ https://site.phages.fr|Phages.fr]]\\ | Membre du bureau d'administration du réseau [[ https://site.phages.fr|Phages.fr]] et [[ https://site.phages.fr/explorerequipes/froissart/|page perso]]\\ |
| UMR 5290 UM-CNRS-IRD\\ | UMR 5290 UM-CNRS-IRD\\ |
| 911 Avenue Agropolis, B.P. 64501 -- Bureau 316 -- 34394 Montpellier Cedex 5, France\\ | 911 Avenue Agropolis, B.P. 64501 -- Bureau 316 -- 34394 Montpellier Cedex 5, France\\ |
| {{:capture_du_2020-06-05_10-41-11.png?200 |}}\\ | {{:capture_du_2020-06-05_10-41-11.png?200 |}}\\ |
| \\ | \\ |
| [[ https://orcid.org/0000-0001-8234-1308|ORCID]]\\ | [[ https://orcid.org/0000-0001-8234-1308|ORCID]] (0000-0001-8234-1308)\\ |
| [[ https://hal.umontpellier.fr/search/index/?q=*&sort=producedDate_tdate+desc&authIdHal_s=remyfroissart|HAL]]\\ | [[ https://hal.umontpellier.fr/search/index/?q=*&sort=producedDate_tdate+desc&authIdHal_s=remyfroissart|HAL]]\\ |
| |
| I also work with [[ https://isem-evolution.fr/membre/martin/|Guillaume Martin]] (CNRS, ISEM, Montpellier, France) and [[ https://www.researchgate.net/profile/Yoann-Anciaux|Yoann Anciaux]] (post-doc ISEM-MIVEGEC, Montpellier, France) on //in vitro// evolutionary rescue of bacteria stressed by antibiotics and/or bacteriophages targetting //E.coli//. I also participate to the project [[ https://www.chu-lyon.fr/antibioresistance-projet-phag-one|Phag-One]] leaded by Frederic Laurent and Tristan Ferry ([[ https://www.crioac-lyon.fr/phagotherapie-bacteriophage/|Hospice Civile de Lyon]]) on the bacteriophage' host-range targetting //Staphylococcus epidermidis// and //E.coli//. Finally, I'm currently also working on //Salmonella// 'bacteriophages in order to perform long-term efficiency of bacteriophage biocontrol. | I also work with [[ https://isem-evolution.fr/membre/martin/|Guillaume Martin]] (CNRS, ISEM, Montpellier, France) and [[ https://www.researchgate.net/profile/Yoann-Anciaux|Yoann Anciaux]] (post-doc ISEM-MIVEGEC, Montpellier, France) on //in vitro// evolutionary rescue of bacteria stressed by antibiotics and/or bacteriophages targetting //E.coli//. I also participate to the project [[ https://www.chu-lyon.fr/antibioresistance-projet-phag-one|Phag-One]] leaded by Frederic Laurent and Tristan Ferry ([[ https://www.crioac-lyon.fr/phagotherapie-bacteriophage/|Hospice Civile de Lyon]]) on the bacteriophage' host-range targetting //Staphylococcus epidermidis// and //E.coli//. Finally, I'm currently also working on //Salmonella// 'bacteriophages in order to perform long-term efficiency of bacteriophage biocontrol. |
| |
| | ====== Collective scientific responsabilities ====== |
| | |
| | {{::logo_phages_fr.png?100|}} |
| | |
| | * Co-animation of the official desk of the GDR "groupement de Recherche" Phages.fr with S. Gandon (CNRS, INEE), M. Ansaldi (CNRS, INSB), C. Breyton (CNRS, INSB), C. Torres-Barceló (INRAe, SPE), F. Lecointe (INRAe, MICA), C. Le Henaff (U. Bordeaux), L. Debarbieux (Institut Pasteur Paris), C. Brives (CNRS, INSHS), F. Leroux (IFREMER). |
| | * Co-animation of the group “phage therapy” of the national network “[[ https://phages.fr|phages.fr]]” |
| | * Co-president with S. Gandon, C. Torres-Barcelo, M. Ansaldi, C. Le Henaff, M-A. Petit, P. Boulanger, L. Debarbieux, C. Brives, E. Rocha of the “Société d’études des bactériophages” |
| | * Responsible for the web site [[ https://phages.fr|phages.fr]] |
| | |
| | {{::logo_mivegec.png?100|}} |
| | * Elected representant to the laboratory council of MIVEGEC (Conseil d'unité) 2021-2026 |
| | * Elected representant to the logistic group of MIVEGEC (2018- ) |
| | * Scientific responsible for the laboratory security (level L2) of MIVEGEC (2016- ) |
| | * APA Correspondant (Nagoya protocol) for MIVEGEC (2021- ) |
| | * Participant of the Science ecological councern group of MIVEGEC (MIVEGEC-1.5) |
| |
| ====== Present position & education ====== | ====== Present position & education ====== |
| ===2021 === | ===2021 === |
| * Brives# C. & R. Froissart. 2021. « [[ https://journals.openedition.org/rac/24239|Évolutions et involutions dans la biomédecine -- Thérapie phagique et traitement des infections bactériennes antibiorésistantes]] ». **Revue d’anthropologie des connaissances** 15-3 | 2021 ("Un tournant microbien ?") ({{ ::rac-24239.pdf |pdf}}) | * Brives# C. & R. Froissart. 2021. « [[ https://journals.openedition.org/rac/24239|Évolutions et involutions dans la biomédecine -- Thérapie phagique et traitement des infections bactériennes antibiorésistantes]] ». **Revue d’anthropologie des connaissances** 15-3 | 2021 ("Un tournant microbien ?") ({{ ::rac-24239.pdf |pdf}}) |
| * Froissart# R. & C. Brives. 2021. « [[ https://doi.org/10.1111/jeb.13904|Evolutionary Biology and Development Model of Medicines: A Necessary “Pas de Deux” for Future Successful Bacteriophage Therapy]] ». **Journal of Evolutionary Biology** ({{ ::froissart_brives_2021_jeb_-_evolutionary_biology_and_development_model_of_medicines_a_necessary_pas_de_deux_for_future_successful_bacteriophage_therapy17162190.pdf |manuscript final}}) | * Froissart# R. & C. Brives. 2021. « [[ https://doi.org/10.1111/jeb.13904|Evolutionary Biology and Development Model of Medicines: A Necessary “Pas de Deux” for Future Successful Bacteriophage Therapy]] ». **Journal of Evolutionary Biology** 34(12):1855-1866 ({{ ::froissart_brives_2021_jeb_-_evolutionary_biology_and_development_model_of_medicines_a_necessary_pas_de_deux_for_future_successful_bacteriophage_therapy17162190.pdf |manuscript final}}) |
| * Happel, Anna-Ursula, Christina Balle, Brandon S. Maust, Iyaloo N. Konstantinus, Katherine Gill, Linda-Gail Bekker, Rémy Froissart, Jo-Ann Passmore, Ulas Karaoz, Arvind Varsani* & Heather Jaspan*. 2021. « [[ https://doi.org/10.3390/v13122341|Presence and Persistence of Putative Lytic and Temperate Bacteriophages in Vaginal Metagenomes from South African Adolescents]] ». **Viruses** 13, nᵒ 12: 2341. | * Happel, Anna-Ursula, Christina Balle, Brandon S. Maust, Iyaloo N. Konstantinus, Katherine Gill, Linda-Gail Bekker, Rémy Froissart, Jo-Ann Passmore, Ulas Karaoz, Arvind Varsani* & Heather Jaspan*. 2021. « [[ https://doi.org/10.3390/v13122341|Presence and Persistence of Putative Lytic and Temperate Bacteriophages in Vaginal Metagenomes from South African Adolescents]] ». **Viruses** 13, nᵒ 12: 2341. |
| * François, Sarah, Aymeric Antoine-Lorquin, Maximilien Kulikowski, Marie Frayssinet, Denis Filloux, Emmanuel Fernandez, Philippe Roumagnac, Rémy Froissart, et Mylène Ogliastro. 2021 « [[ https://doi.org/10.3390/v13050791|Characterisation of the Viral Community Associated with the Alfalfa Weevil (Hypera Postica) and Its Host Plant, Alfalfa (Medicago Sativa)]] ». **Viruses** 13, nᵒ 5 (may 2021): 791. | * François, Sarah, Aymeric Antoine-Lorquin, Maximilien Kulikowski, Marie Frayssinet, Denis Filloux, Emmanuel Fernandez, Philippe Roumagnac, Rémy Froissart, et Mylène Ogliastro. 2021 « [[ https://doi.org/10.3390/v13050791|Characterisation of the Viral Community Associated with the Alfalfa Weevil (Hypera Postica) and Its Host Plant, Alfalfa (Medicago Sativa)]] ». **Viruses** 13, nᵒ 5 (may 2021): 791. |
| - Graduate studies : __Yann Dumont__ (2019-2022, co-suppervision with Pr S. Godreuil, CHU Montpellier), __Anna Happel__ (2017-2020, co-direction with Jo-Ann Passmore, U. Cape-Town), __Sarah François__ (2014-2017, co-suppervision with Dr M. Ogliastro, INRAE), __Juliette Doumayrou__ (2008-2011, co-suppervision with Yannis Michalakis, CNRS) | - Graduate studies : __Yann Dumont__ (2019-2022, co-suppervision with Pr S. Godreuil, CHU Montpellier), __Anna Happel__ (2017-2020, co-direction with Jo-Ann Passmore, U. Cape-Town), __Sarah François__ (2014-2017, co-suppervision with Dr M. Ogliastro, INRAE), __Juliette Doumayrou__ (2008-2011, co-suppervision with Yannis Michalakis, CNRS) |
| |
| ====Grant proposal==== | ====PhD in progress==== |
| 2022 : application to a FRM grant (Fondation pour la Recherche Médicale) -- looking for master'student ! Here is the presentation of the subject I would like to study with the graduate student : "[[2022_FRM_appl_grant|Study of the antagonistic co-evolution between therapeutic bacteriophages and E. coli carbapenem-resistant]]" | 2022-2025 : "**Salmonella biocontrol**" -- in charge : Amandine Maurin |
| | |
| | 2022-2025 : "**Study of the antagonistic co-evolution between therapeutic bacteriophages and carbapenem-resistant E. coli**" - in charge Elsa Beurrier |
| | |
| | 2024-2024 : "**étude des savoirs, savoir-faire et enjeux de la domestication de bactériophages à usages thérapeutiques**" - in charge Charlotte Whittington (co-direction avec Charlotte Brives (CNRS, Bordeaux) |
| |
| ====== Technical skills ====== | ====== Technical skills ====== |
| * stats : JMP - (r) | * stats : JMP - (r) |
| * biblio : zotero | * biblio : zotero |
| ====== Grants ====== | ====== Grants (current and recent) ====== |
| | |
| | * 2023-2024 **Défi-clé OCTAAVE -- Région Occitanie** : "OcciPhage : Diversité et emploi de bactériophages à potentiel de lutte biologique contre les bactéries pathogènes de cultures tempérées et tropicales" -- collaboration with Boris Szurek (UMR PHIM Montpellier) & Alice Boulanger (UMR LIPME Toulouse) |
| | |
| | * 2021-2027 **ANR Antibio-résistance** : Phag-One : isolation, production and application of therapeutical bacteriophages targeting Staphylococcus sp. or E. coli resistant to carbapenems" -- collaboration with Pr Frédéric Laurent, Hospices civiles de Lyon |
| | |
| | * 2019-2025 **Contrat privé** "Salmonella biocontrol in animal food production" |
| |
| * **Projet Hubert Curien (PHC) PROTEA** - Campus France - Afrique du Sud 2019-2020 | * 2019-2020 **Projet Hubert Curien (PHC) PROTEA** - Campus France - Afrique du Sud -- "Évaluation de l'inflammation génitale provoquée par des isolats bactériens associés à la vaginose dans un contexte de risque d'acquisition de HIV" -- collaboration with Jo-Ann Passmore, UCT |
| "Évaluation de l'inflammation génitale provoquée par des isolats bactériens associés à la vaginose dans un contexte de risque d'acquisition de HIV" | |
| |
| * **Bourse du labex CEMEB** 2018-2020 | * 2018-2020 **Bourse du labex CEMEB** -- “Evolutionary rescue of bacterial populations facing bacteriophages, antibiotics and a combination of both stresses” Collaboration with Guillaume Martin, ISEM, Montpellier, France. |
| “Evolutionary rescue of bacterial populations facing bacteriophages, antibiotics and a combination of both stresses” Collaboration with Guillaume Martin, ISEM, Montpellier, France. | |
| |
| * **International Collaborative grant – Univ. Cape-Town / Univ. Montpellier II** 2015-2017 | * 2015-2017 **International Collaborative grant – Univ. Cape-Town / Univ. Montpellier II** -- “Role of bacteriophages in development of bacterial vaginosis in women at high risk for HIV infection” collaboration with Jo-Ann Passmore, Medical Virology, University of Cape-Town, South-Africa. |
| “Role of bacteriophages in development of bacterial vaginosis in women at high risk for HIV infection” with Jo-Ann Passmore, Medical Virology, University of Cape-Town, South-Africa. | |
| |
| |
| * Co-animation with L. Debarbieux of the group “phage therapy” of the national network “phages.fr” 2017-- | * Co-animation with L. Debarbieux of the group “phage therapy” of the national network “phages.fr” 2017-- |
| * Co-president with S. Gandon, C. Torres-Barcelo, M. Ansaldi, C. Le Henaff, M-A. Petit, P. Boulanger, L. Debarbieux, C. Brives, E. Rocha of the “Société d’études des bactériophages” | * Co-president with S. Gandon, C. Torres-Barcelo, M. Ansaldi, C. Le Henaff, M-A. Petit, P. Boulanger, L. Debarbieux, C. Brives, E. Rocha of the “Société d’études des bactériophages” |
| * Responsible for the web site www.phages.fr | * Responsible for the web site [[ https://phages.fr|phages.fr]] |
| |
| ====== DIVERS ====== | ====== DIVERS ====== |
